1. World Health Organization. Control of leishmaniases. Technical Report Series 949. WHO Expert Committee. Geneva, Switzerland. WHO. 2010.
2. Alvar J, Velez ID, Bern C, Herrero M, Desjeux P, Cano J, Jannin J, den Boer M; WHO
Leishmaniasis Control Team.
Leishmaniasis worldwide and global estimates of its incidence. PLoS One 2012;7:e35671.
3. Postigo JA. Leishmaniasis in the World Health Organization Eastern Mediterranean Region. Int J Antimicrob Agents 2010;36(suppl 1):S62-S65.
4. Mohebali M. Visceral
leishmaniasis in Iran: review of the epidemiological and clinical features. Iran J Parasitol 2013;8:348-358.
5. Mohebali M, Edrissian GH, Shirzadi MR, Akhoundi B, Hajjaran H, Zarei Z, Molaei S, Sharifi I, Mamishi S, Mahmoudvand H, Torabi V, Moshfe A, Malmasi A, Motazedian MH, Fakhar M. An observational study on the current distribution of visceral
leishmaniasis in different geographical zones of Iran and implication to health policy. Travel Med Infect Dis 2011;9:67-74.
6. Bahrami A, Rassi Y, Maleki N, Oshaghi MA, Mohebali M, Yagoobi-Ershadi MR, Rafizadeh S.
Leishmania infantum DNA detection in
Phlebotomus tobbi in a new northern focus of visceral
leishmaniasis in Iran. Asian Pac J Trop Dis 2014;4:110-114.
7. Tofighi Naeem A, Mahmoudi S, Saboui F, Hajjaran H, Pourakbari B, Mohebali M, Zarkesh MR, Mamishi S. Clinical features and laboratory findings of visceral leishmaniasis in children referred to Children Medical Center hospital, Tehran, Iran during 2004-2011. Iran J Parasitol 2014;9:1-5.
8. Bokaie S, Sharifi L, Mamishi S, Nadim A. A case series study on clinical and epidemiologic aspects of Kala Azar in patients referred to the Children's Medical Center since 1991 to 2003. Iran J Epidemiol 2006;1(3-4):21-26 (in Iranian).
9. Mohebali M, Edrissian Gh H, Nadim A, Hajjaran H, Akhoundi B, Hooshmand B, Zarei Z, Arshi SH, Mirsamadi N, Manouchehri Naeini K, Mamishi S, Sanati AA, Moshfe AA, Charehdar S, Fakhar M. Application of direct agglutination test (DAT) for the diagnosis and seroepidemiological studies of visceral leishmaniasis in Iran. Iran J Parasitol 2006;1:15-25.
10. Harith A, Kolk AH, Leeuwenburg J, Muigai R, Huigen E, Jelsma T, Kager PM. Improvement of a direct agglutination test for field studies of visceral
leishmaniasis. J Clin Microbiol 1988;26:1321-1325.
11. Boelaert M, Safi S, Jacquet D, Muynck A, Van der Stuyft P, Le Ray D. Operational validation of the direct agglutination test for diagnosis of visceral
leishmaniasis. Am J Trop Med Hyg 1999;60:129-134.
13. Mohebali M, Hajjaran H, Hamzavi Y, Mobedi I, Arshi S, Zarei Z, Akhoundi B, Naeini KM, Avizeh R, Fakhar M. Epidemiological aspects of canine visceral
leishmaniasis in the Islamic Republic of Iran. Vet Parasitol 2005;129:243-251.
15. Mahmoudvand H, Mohebali M, Sharifi I, Keshavarz H, Hajjaran H, Akhoundi B, Jahanbakhsh S, Zarean M, Javadi A. Epidemiological aspects of visceral leishmaniasis in Baft district, Kerman Province, Southeast of Iran. Iran J Parasitol 2011;6:1-11.
16. Torabi V, Mohebali M, Edrissian Gh H, Keshavarz H, Mohajeri M, Hajjaran H, Akhoundi B, Sanati AA, Zarei Z, Delshad A. Seroepidemiological survey of visceral leishmaniasis by direct agglutination test in Bojnoord District, north Khorasan Province in 2007. Iran J Epidemiol 2009;4:43-50 (in Iranian).
17. Mahami M, Mohebali M, Keshavarz H, Hajaran H, Akhoondi B, Zarei Z, Charedar S. Seroepidemiological survey of visceral leishmaniasis (Kala-azar) in Germi district, Ardabil Province. J School Public Health Inst Public Health Res 2006;4:45-55.
18. Sarkari B, Pedram N, Mohebali M, Moshfe AA, Zargar MA, Akhoundi B, Shirzadi MR. Seroepidemiological study of visceral
leishmaniasis in Booyerahmad district, south-west Islamic Republic of Iran. East Mediterr Health J 2010;16:1133-1136.
19. Hamzavi Y, Hamzeh B, Mohebali M. Human visceral
leishmaniasis in Kermanshah province, western Iran, during 2011-2012. Iran J Parasitol 2012;7:49-56.
20. Gidwani K, Kumar R, Rai M, Sundar S. Longitudinal seroepidemiologic study of visceral
leishmaniasis in hyperendemic regions of Bihar, India. Am J Trop Med Hyg 2009;80:345-346.
21. Sakru N, Korkmaz M, Ozbel Y, Ertabaklar H, Sengul M, Toz SO. Investigation of asymptomatic visceral
leishmaniasis cases using western blot in an endemic area in Turkey. New Microbiol 2007;30:13-18.
22. Sisko-Kraljević K, Jeroncic A, Mohar B, Punda-Polic V. Asymptomatic
Leishmania infantum infections in humans living in endemic and non-endemic areas of Croatia, 2007 to 2009. Euro Surveill 2013;18:20533.
23. Badaro R, Jones TC, Lorenço R, Cerf BJ, Sampaio D, Carvalho EM, Rocha H, Teixeira R, Johnson WD Jr. A prospective study of visceral
leishmaniasis in an endemic area of Brazil. J Infect Dis 1986;154:639-649.
24. Adel A, Boughoufalah A, Saegerman C, De Deken R, Bouchene Z, Soukehal A, Berkvens D, Boelaert M. Epidemiology of visceral
leishmaniasis in Algeria: an update. PLoS One 2014;9:e99207.
26. Tanir G, Taylan Ozkan A, Daglar E. Pediatric visceral
leishmaniasis in Turkey. Pediatr Int 2006;48:66-69.
27. Haddadzade HR, Fattahi R, Mohebali M, Akhoundi B, Ebrahimzade E. Seroepedimiological investigation of visceral
lesihmaniasis in stray and owned dogs in Alborz province, Central Iran using direct agglutination test. Iran J Parasitol 2013;8:152-157.